Skip to main content

Table 1 Databases and keywords used in search strategies

From: Over-the-counter use of short-acting beta-2 agonists: a systematic review

Database

Search strategy

PubMed

((("overuse"[All Fields] OR "overused"[All Fields] OR "overuser"[All Fields] OR "overusers"[All Fields] OR "overuses"[All Fields] OR "overusing"[All Fields] OR ("misuse"[All Fields] OR "misused"[All Fields] OR "misuser"[All Fields] OR "misusers"[All Fields] OR "misuses"[All Fields] OR "misusing"[All Fields]) OR ("excess"[All Fields] OR "excesses"[All Fields] OR "excessive"[All Fields] OR "excessively"[All Fields])) AND ("nonprescription drugs"[MeSH Terms] OR ("nonprescription"[All Fields] AND "drugs"[All Fields]) OR "nonprescription drugs"[All Fields] OR ("over"[All Fields] AND "counter"[All Fields]) OR "over the counter"[All Fields] OR "OTC"[All Fields] OR ("communal"[All Fields] OR "communalism"[All Fields] OR "communalities"[All Fields] OR "communality"[All Fields] OR "communally"[All Fields] OR "commune"[All Fields] OR "communes"[All Fields] OR "community s"[All Fields] OR "communitys"[All Fields] OR "residence characteristics"[MeSH Terms] OR ("residence"[All Fields] AND "characteristics"[All Fields]) OR "residence characteristics"[All Fields] OR "communities"[All Fields] OR "community"[All Fields]) OR (("retail"[All Fields] OR "retailed"[All Fields] OR "retailer"[All Fields] OR "retailer s"[All Fields] OR "retailers"[All Fields] OR "retailing"[All Fields] OR "retails"[All Fields]) AND ("pharmacie"[All Fields] OR "pharmacies"[MeSH Terms] OR "pharmacies"[All Fields] OR "pharmacy"[MeSH Terms] OR "pharmacy"[All Fields] OR "pharmacy s"[All Fields])) OR ("prescriptions"[MeSH Terms] OR "prescriptions"[All Fields] OR "prescription"[All Fields]) OR "non-prescriptions"[All Fields])) OR (("short-acting"[All Fields] AND "beta-2"[All Fields] AND ("agonist"[All Fields] OR "agonist s"[All Fields] OR "agonistic"[All Fields] OR "agonistically"[All Fields] OR "agonistics"[All Fields] OR "agonists"[MeSH Subheading] OR "agonists"[All Fields])) OR ("3 2 4 azidobenzamidino ethyl 5 hydroxyindole"[Supplementary Concept] OR "3 2 4 azidobenzamidino ethyl 5 hydroxyindole"[All Fields] OR "saba"[All Fields]) OR ("levalbuterol"[MeSH Terms] OR "levalbuterol"[All Fields] OR "albuterol"[All Fields] OR "albuterol"[MeSH Terms] OR "salbutamol"[All Fields]) OR ("terbutaline"[MeSH Terms] OR "terbutaline"[All Fields] OR "terbutalin"[All Fields]) OR ("levalbuterol"[MeSH Terms] OR "levalbuterol"[All Fields] OR "albuterol"[All Fields] OR "albuterol"[MeSH Terms] OR "salbutamol"[All Fields]) OR (("asthma"[MeSH Terms] OR "asthma"[All Fields] OR "asthmas"[All Fields] OR "asthma s"[All Fields]) AND ("reliever"[All Fields] OR "relievers"[All Fields])))) AND ((booksdocs[Filter] OR clinicaltrial[Filter] OR randomizedcontrolledtrial[Filter]) AND (fft[Filter]) AND (2000:2023[pdat])

Scopus

TITLE-ABS-KEY ((overuse OR misuse OR excessive AND use) AND ( over-the-counter OR otc OR community OR retail AND pharmacy OR without AND prescriptions OR non-prescriptions) OR (short-acting AND beta-2 AND agonists OR saba OR salbutamol OR terbutaline OR albuterol OR asthma AND reliever)) AND (LIMIT-TO (PUBYEAR, 2023) OR LIMIT-TO (PUBYEAR, 2022) OR LIMIT-TO (PUBYEAR, 2021) OR LIMIT-TO (PUBYEAR, 2020) OR LIMIT-TO (PUBYEAR, 2019) OR LIMIT-TO (PUBYEAR, 2018) OR LIMIT-TO (PUBYEAR, 2017) OR LIMIT-TO (PUBYEAR, 2016) OR LIMIT-TO (PUBYEAR, 2015) OR LIMIT-TO (PUBYEAR, 2014) OR LIMIT-TO (PUBYEAR, 2013) OR LIMIT-TO (PUBYEAR, 2012) OR LIMIT-TO (PUBYEAR, 2011) OR LIMIT-TO (PUBYEAR, 2010) OR LIMIT-TO (PUBYEAR, 2009) OR LIMIT-TO (PUBYEAR, 2008) OR LIMIT-TO (PUBYEAR, 2007) OR LIMIT-TO (PUBYEAR, 2006) OR LIMIT-TO (PUBYEAR, 2005) OR LIMIT-TO (PUBYEAR, 2004) OR LIMIT-TO (PUBYEAR, 2003) OR LIMIT-TO (PUBYEAR, 2002) OR LIMIT-TO (PUBYEAR, 2001) OR LIMIT-TO (PUBYEAR, 2000)) AND (LIMIT-TO (DOCTYPE, "ar")) AND (LIMIT-TO ( LANGUAGE, "English"))

Springer Link

(Overuse OR misuse OR excessive AND use) AND (over-the-counter OR otc OR community OR retail AND pharmacy OR without AND prescriptions OR non-prescriptions) OR (short-acting AND beta-2 AND agonists OR saba OR salbutamol OR terbutaline OR albuterol OR asthma AND reliever)

Within English, Article, 2000–2023

Google Scholar

(Overuse OR misuse OR excessive AND use) AND (over-the-counter OR otc OR community OR retail AND pharmacy OR without AND prescriptions OR non-prescriptions) OR (short-acting AND beta-2 AND agonists OR saba OR salbutamol OR terbutaline OR albuterol OR asthma AND reliever)

(Filter: 2000–2023)

CINAHL

(Overuse OR misuse OR excessive AND use) AND (over-the-counter OR otc OR community OR retail AND pharmacy OR without AND prescriptions OR non-prescriptions) OR (short-acting AND beta-2 AND agonists OR saba OR salbutamol OR terbutaline OR albuterol OR asthma AND reliever)

(Filter: Online content only (All articles and eBook), Journal article, Publication date from 2000 to 2023)

APA PsycArticles

(Overuse OR misuse OR excessive AND use) AND (over-the-counter OR otc OR community OR retail AND pharmacy OR without AND prescriptions OR non-prescriptions) OR (short-acting AND beta-2 AND agonists OR saba OR salbutamol OR terbutaline OR albuterol OR asthma AND reliever)